SWEET proteins facilitate transmembrane sugar transport, critical for carbohydrate partitioning in plants. While SWEET7D’s exact role remains uncharacterized in the provided literature, its classification within the SWEET family suggests involvement in:
Structural analysis of SWEET homologs reveals a conserved seven-transmembrane helix architecture, though SWEET7D’s unique sequence (UniProt B9G2E6) may confer distinct substrate preferences .
The SWEET7D Antibody exemplifies advancements in antibody generation pipelines, which increasingly leverage:
High-throughput validation using knockout (KO) cell lines to confirm specificity .
Cross-species reactivity screens to minimize off-target binding .
While validation data for SWEET7D are not explicitly provided, industry standards emphasize the necessity of:
The SWEET7D Antibody enables:
| Application | Use Case |
|---|---|
| Western Blotting | Quantifying SWEET7D expression under stress conditions |
| Immunoprecipitation | Isolating SWEET7D-interacting proteins |
| Cellular Localization | Mapping subcellular distribution in rice tissues |
These applications align with broader trends in plant physiology research, particularly in studying carbohydrate metabolism .
Proteome-scale initiatives like YCharOS advocate for:
SWEET7D belongs to the SWEET (Sugars Will Eventually be Exported Transporters) family of proteins found in Oryza sativa subsp. japonica (Rice). These proteins play crucial roles in sugar transport across cellular membranes, making them vital for understanding plant physiology related to carbohydrate allocation, growth, and response to environmental stressors. The SWEET7D antibody allows researchers to specifically detect and quantify this protein, enabling investigations into sugar transport mechanisms, plant development, and stress responses. This antibody targets a specific SWEET7D protein with UniProt accession number B9G2E6, which is essential for precise identification in experimental settings .
The SWEET7D antibody is a polyclonal antibody raised in rabbit against recombinant Oryza sativa subsp. japonica SWEET7D protein. It is supplied in liquid form with a storage buffer containing 0.03% Proclin 300 as a preservative, 50% glycerol, and 0.01M PBS at pH 7.4. The antibody is purified using an antigen affinity method and is of IgG isotype. It demonstrates specific reactivity to Oryza sativa subsp. japonica and has been validated for applications including ELISA and Western Blotting (WB). For long-term storage, it should be kept at -20°C or -80°C, with researchers advised to avoid repeated freeze-thaw cycles that may compromise antibody functionality .
SWEET7D antibody specifically targets the SWEET7D protein (UniProt: B9G2E6) in rice, distinguishing it from antibodies that target other members of the SWEET family or other sugar transporters. Unlike antibodies for SWEET1-4 that are primarily involved in hexose transport, or SWEET11-15 that mediate sucrose transport, SWEET7D antibody enables research on clade-specific transport functions. The specificity of this antibody allows researchers to distinguish the unique roles of SWEET7D in rice development and stress responses from other sugar transporters. This specificity is critical when investigating the differential expression and localization patterns of various sugar transporters within plant tissues. Understanding these differences is essential for accurate experimental design in comparative studies of sugar transport mechanisms in plants.
For optimal Western blot results with SWEET7D antibody, researchers should follow this methodology:
Sample preparation: Extract total protein from rice tissues using a buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, and protease inhibitor cocktail. Quantify using Bradford assay.
Gel electrophoresis: Load 20-50μg protein per lane on a 10-12% SDS-PAGE gel. Include positive and negative controls.
Transfer: Use PVDF membrane with semi-dry transfer at 15V for 30-45 minutes.
Blocking: Block with 5% non-fat dry milk in TBST (TBS + 0.1% Tween-20) for 1 hour at room temperature.
Primary antibody incubation: Dilute SWEET7D antibody 1:1000 to 1:2000 in blocking solution and incubate overnight at 4°C.
Washing: Wash membrane 3-4 times with TBST, 5 minutes each.
Secondary antibody: Incubate with HRP-conjugated anti-rabbit IgG (1:5000) for 1 hour at room temperature.
Signal development: Use enhanced chemiluminescence (ECL) substrate and expose to X-ray film or digital imager.
For membrane proteins like SWEET7D, sample preparation is particularly critical. Avoid boiling samples for extended periods as this may cause membrane protein aggregation. The expected molecular weight for SWEET7D protein should be verified against relevant literature to confirm specificity of detection .
For successful immunolocalization of SWEET7D protein in plant tissues:
Tissue fixation: Fix fresh rice tissue samples in 4% paraformaldehyde in PBS (pH 7.4) for 4-6 hours at 4°C.
Tissue processing: Dehydrate through an ethanol series, clear in xylene, and embed in paraffin or optimal cutting temperature (OCT) compound for cryosectioning.
Sectioning: Prepare 5-8μm thick sections on positively charged slides.
Antigen retrieval: Perform heat-induced epitope retrieval using citrate buffer (pH 6.0) for 10 minutes.
Blocking: Block with 3% BSA in PBS containing 0.1% Triton X-100 for 1 hour at room temperature.
Primary antibody: Apply SWEET7D antibody diluted 1:100 to 1:500 in blocking solution and incubate overnight at 4°C in a humidity chamber.
Washing: Wash sections 3 times with PBS containing 0.1% Tween-20.
Secondary antibody: Apply fluorophore-conjugated anti-rabbit secondary antibody (1:200-1:500) for 1-2 hours at room temperature.
Counterstaining: Use DAPI (1μg/ml) to visualize nuclei.
Mounting and imaging: Mount with anti-fade mounting medium and examine using confocal microscopy.
For co-localization studies, combine SWEET7D antibody with other organelle markers (e.g., plasma membrane, ER, or Golgi markers) to precisely determine the subcellular localization of SWEET7D protein. This approach can provide valuable insights into the functional role of SWEET7D in sugar transport pathways within plant cells.
For quantitative detection of SWEET7D protein using ELISA:
Plate coating: Coat 96-well plates with capture antibody (anti-SWEET7D) diluted 1:500 in carbonate-bicarbonate buffer (pH 9.6), incubate overnight at 4°C.
Blocking: Block with 3% BSA in PBS-T (PBS + 0.05% Tween-20) for 1-2 hours at room temperature.
Sample preparation: Extract proteins from rice tissues using a non-denaturing buffer. Prepare a standard curve using recombinant SWEET7D protein.
Sample incubation: Add samples and standards to wells, incubate for 2 hours at room temperature.
Detection antibody: Apply biotinylated anti-SWEET7D antibody (1:1000) for 1 hour at room temperature.
Signal amplification: Add streptavidin-HRP (1:5000) for 30 minutes.
Substrate reaction: Add TMB substrate, incubate for 15-30 minutes in the dark.
Stop reaction: Add 2N H₂SO₄ to stop the reaction.
Measurement: Read absorbance at 450nm with reference at 620nm.
Data analysis: Calculate SWEET7D concentrations based on the standard curve.
For sandwich ELISA, ensure that the capture and detection antibodies recognize different epitopes on the SWEET7D protein to avoid steric hindrance. Validate the linear range of detection and establish appropriate positive and negative controls to ensure reliability of results .
SWEET7D antibody can be instrumental in studying drought stress responses in rice through several methodological approaches:
Expression profiling: Compare SWEET7D protein levels in drought-stressed versus well-watered rice plants using Western blot analysis with SWEET7D antibody. This reveals how drought affects SWEET7D expression.
Tissue-specific analysis: Perform immunohistochemistry with SWEET7D antibody on different rice tissues (leaves, roots, stems) under drought conditions to identify tissue-specific regulation.
Time-course experiments: Analyze SWEET7D expression at different time points during drought stress and recovery periods to understand temporal dynamics.
Co-immunoprecipitation: Use SWEET7D antibody to identify interacting partner proteins under drought stress conditions, potentially revealing novel regulatory mechanisms.
Transgenic complementation: In SWEET7D knockout or knockdown lines, verify the success of complementation experiments by detecting restored protein expression using the antibody.
The methodology should include parallel analyses of transcript levels (via RT-qPCR) and protein levels (via Western blot) to distinguish between transcriptional and post-transcriptional regulation mechanisms. Additionally, researchers should correlate SWEET7D protein levels with physiological parameters such as photosynthetic rates, stomatal conductance, and sugar content in various tissues to establish functional relationships between SWEET7D activity and drought adaptation mechanisms.
Different fixation methods significantly impact SWEET7D antibody performance in immunohistochemistry, with important methodological considerations:
| Fixation Method | Advantages | Disadvantages | Recommended Protocol |
|---|---|---|---|
| Paraformaldehyde (4%) | Preserves protein antigenicity while maintaining tissue morphology | May require antigen retrieval | Fix for 4-6 hours at 4°C, followed by citrate buffer antigen retrieval |
| Glutaraldehyde (0.5-2%) | Superior ultrastructural preservation | Can cause high background and reduced antibody access | Use at low concentrations (0.5%) combined with paraformaldehyde (3%) |
| Methanol | Good for membrane proteins, simple procedure | Poor preservation of cytoplasmic structures | Fix at -20°C for 10 minutes, no antigen retrieval needed |
| Acetone | Excellent for preservation of antigenicity | Poor morphological preservation | Fix at -20°C for 10 minutes, best for cryosections |
| Fresh-frozen sections | Minimal epitope modification | Poor morphological preservation | Flash-freeze in liquid nitrogen, section without fixation |
For membrane proteins like SWEET7D, a combination approach often yields optimal results: fix tissues briefly with 4% paraformaldehyde (30 minutes at room temperature), followed by post-fixation in cold methanol for enhanced membrane protein detection. This methodology preserves both tissue structure and SWEET7D antigenicity. Always perform parallel experiments with different fixation protocols when optimizing for a new tissue type or experimental condition to determine the optimal method for specific research needs.
Detecting post-translational modifications (PTMs) of SWEET7D requires specialized methodological approaches:
Phosphorylation detection:
Combine SWEET7D antibody with phospho-specific antibodies in Western blot analyses
Perform immunoprecipitation with SWEET7D antibody followed by phospho-specific staining
Use lambda phosphatase treatment as a control to confirm phosphorylation
Apply Phos-tag™ gel electrophoresis to separate phosphorylated from non-phosphorylated forms
Glycosylation analysis:
Compare migration patterns before and after treatment with glycosidases
Use lectins in combination with SWEET7D antibody for co-localization studies
Employ periodic acid-Schiff (PAS) staining after immunoprecipitation
Ubiquitination detection:
Immunoprecipitate with SWEET7D antibody followed by ubiquitin antibody detection
Use proteasome inhibitors to accumulate ubiquitinated forms
Perform size comparison under reducing and non-reducing conditions
Methods for other PTMs:
SUMOylation: Immunoprecipitate with SWEET7D antibody followed by SUMO antibody detection
Acetylation: Use acetylation-specific antibodies after SWEET7D immunoprecipitation
These approaches should include appropriate controls to validate specificity, such as comparing wild-type plants with those expressing mutated SWEET7D versions where putative modification sites have been altered. Cross-validation using mass spectrometry analysis of immunoprecipitated SWEET7D protein can provide definitive identification of modification sites and types.
Common pitfalls in SWEET7D antibody experiments include:
High background signal:
Problem: Non-specific binding to other plant proteins
Solution: Increase blocking time/concentration (use 5% BSA instead of 3%), optimize antibody dilution (try 1:2000 instead of 1:1000), include 0.1% Tween-20 in wash buffers, and perform additional washing steps
Weak or no signal detection:
Problem: Insufficient antigen, degraded antibody, or inefficient extraction
Solution: Increase protein concentration, use fresh antibody aliquots, optimize extraction buffer (add more detergent for membrane proteins), extend primary antibody incubation time, or try enhanced detection systems
Multiple bands in Western blot:
Problem: Protein degradation, cross-reactivity, or post-translational modifications
Solution: Add additional protease inhibitors, perform peptide competition assays to confirm specificity, or include phosphatase/glycosidase treatments to verify modifications
Irreproducible results:
Problem: Variation in experimental conditions or sample preparation
Solution: Standardize all protocols, prepare master mixes, use consistent positive controls, and normalize loading with housekeeping proteins
Poor tissue penetration in immunohistochemistry:
Problem: Insufficient permeabilization or fixation issues
Solution: Optimize Triton X-100 concentration (try 0.2-0.5% instead of 0.1%), extend antigen retrieval time, or test different fixation methods
For each troubleshooting approach, systematic protocol optimization with controlled changes to one variable at a time is recommended. Document all optimization steps methodically to establish reliable protocols for future experiments.
Validating SWEET7D antibody specificity requires multiple complementary approaches:
Genetic validation:
Compare antibody reactivity between wild-type plants and SWEET7D knockout/knockdown lines
Test reactivity in plants overexpressing tagged SWEET7D protein
Analyze cross-reactivity with other SWEET family members in plants with selective gene expression
Biochemical validation:
Perform peptide competition assays using the immunizing peptide
Conduct pre-adsorption tests with recombinant SWEET7D protein
Compare reactivity patterns with antibodies targeting different SWEET7D epitopes
Analytical validation:
Correlate protein detection with mRNA expression data
Verify expected molecular weight and subcellular localization
Confirm detection in tissues known to express SWEET7D
Cross-platform validation:
Compare results between different detection methods (Western blot, ELISA, immunohistochemistry)
Verify with orthogonal methods like mass spectrometry after immunoprecipitation
Use epitope-tagged SWEET7D constructs in parallel experiments
A comprehensive validation protocol should include positive controls (tissues with known high SWEET7D expression) and negative controls (tissues or conditions with minimal expression) to establish a dynamic range for detection. Documentation of all validation experiments is essential for publication and experimental reproducibility.
Advanced techniques integrating SWEET7D antibody with other methodologies include:
Proximity ligation assay (PLA):
Methodology: Combine SWEET7D antibody with antibodies against putative interacting proteins
Application: Detect protein-protein interactions in situ with subcellular resolution
Advantage: Visualizes transient interactions that may be lost in co-immunoprecipitation
ChIP-Western analysis:
Methodology: Use SWEET7D antibody for Western blot validation after chromatin immunoprecipitation
Application: Verify transcription factor binding to SWEET7D promoter regions
Advantage: Connects transcriptional regulation directly to protein expression
FRET-FLIM with antibody-based detection:
Methodology: Label SWEET7D antibody and interaction partner antibodies with compatible fluorophores
Application: Measure protein-protein interaction dynamics in live or fixed cells
Advantage: Provides quantitative spatial and temporal information on interactions
Super-resolution microscopy:
Methodology: Use fluorophore-conjugated SWEET7D antibodies with STORM, PALM, or STED microscopy
Application: Visualize nanoscale distribution of SWEET7D proteins in membranes
Advantage: Overcomes diffraction limit to reveal protein organization not visible with conventional microscopy
Quantitative proteomics integration:
Methodology: Combine SWEET7D immunoprecipitation with LC-MS/MS analysis
Application: Identify and quantify the SWEET7D interactome under different conditions
Advantage: Provides unbiased identification of novel interaction partners and post-translational modifications
Artificial intelligence approaches offer several promising avenues for improving SWEET7D antibody design and applications:
Epitope prediction and optimization:
AI algorithms can analyze SWEET7D protein structure to identify optimal epitopes for antibody generation
Machine learning models trained on antibody-antigen interaction data can predict epitopes with greater immunogenicity and specificity
These approaches can design antibodies that target functionally important domains of SWEET7D
AI-driven structural design:
Programs like RFdiffusion can generate novel antibody structures targeting specific SWEET7D epitopes
This approach can design antibodies with improved specificity, reducing cross-reactivity with other SWEET family members
AI can optimize the complementarity-determining regions (CDRs) for enhanced binding affinity
Prediction of post-translational modifications:
AI algorithms can predict likely PTM sites on SWEET7D protein, guiding the development of modification-specific antibodies
These tools can distinguish PTMs that occur under different physiological conditions, enabling more targeted antibody development
Application optimization:
Machine learning can analyze experimental variables to optimize antibody performance in specific applications
Predictive models can determine optimal conditions for SWEET7D detection across different techniques
The methodology for implementing AI approaches would involve training models on existing antibody-antigen interaction data, structural databases, and experimental results from similar membrane proteins. These models could then generate predictions that would be experimentally validated and refined through iterative testing and optimization cycles .
Developing and using SWEET7D antibodies across different plant species requires careful consideration of several factors:
Sequence conservation analysis:
Perform multiple sequence alignments of SWEET7D homologs across target plant species
Identify conserved epitopes for broad-specificity antibodies versus species-specific regions
Design antibodies against conserved regions for cross-species applications
Species validation protocol:
Test antibody reactivity systematically across phylogenetically diverse plant species
Establish a validation pipeline including Western blot, immunohistochemistry, and ELISA for each species
Document species-specific modifications to protocols needed for optimal results
Cross-reactivity management:
Pre-absorb antibodies with proteins from non-target species to improve specificity
Use competitive ELISAs to quantify relative affinities across species variants
Develop calibration curves for quantitative comparisons across species
Species-specific controls:
Generate knockout/knockdown lines in each species where possible
Create recombinant protein standards from each species' SWEET7D variant
Develop species-specific reference materials for standardization
The methodological approach should include antibody epitope mapping against multiple SWEET7D homologs, followed by systematic testing across species with appropriate positive and negative controls. Researchers should document species-specific protocol modifications and validation metrics to ensure reliable cross-species applications. This approach enables comparative studies of SWEET7D function across different plant taxa, contributing to broader understanding of sugar transport evolution in plants.
The integration of SWEET7D antibody research with genome editing technologies offers several powerful research applications:
CRISPR-engineered validation systems:
Generate precise SWEET7D knockout lines using CRISPR/Cas9 for antibody specificity validation
Create epitope-tagged SWEET7D variants at endogenous loci for antibody calibration
Develop allelic series with modified post-translational modification sites to study their functional relevance
Structure-function analysis:
Introduce point mutations in functional domains and use antibodies to track protein expression/localization
Engineer chimeric SWEET proteins and use domain-specific antibodies to study protein dynamics
Create truncation series to map antibody epitopes precisely
Regulatory studies:
Edit promoter elements and use antibodies to quantify effects on protein expression
Modify introns/UTRs and track resulting changes in protein levels via immunodetection
Generate inducible expression systems for temporal studies of SWEET7D function
Advanced applications:
Combine optogenetic control of SWEET7D expression with antibody-based detection for dynamic studies
Create synthetic regulatory circuits with antibody-based readouts of SWEET7D expression
Develop SWEET7D biosensors using antibody-based detection systems
The methodological approach should follow this sequence: (1) design and validate genome editing constructs, (2) generate and genotype edited plant lines, (3) verify edits at the DNA and RNA levels, (4) use SWEET7D antibodies to assess protein-level consequences, and (5) correlate protein data with phenotypic analyses. This integrated approach provides comprehensive understanding of SWEET7D function from genotype to phenotype, with antibodies serving as critical tools for detecting the protein-level effects of genomic modifications.
Emerging technologies poised to revolutionize SWEET7D antibody applications include nanobody development for improved membrane protein detection, single-cell immunoassays for cell-specific expression analysis, and multiplexed imaging techniques for simultaneous detection of multiple sugar transporters. Advanced cryo-electron microscopy combined with antibody labeling could reveal SWEET7D's native membrane conformation and transport mechanism. Additionally, microfluidic antibody arrays may enable high-throughput screening of SWEET7D expression across multiple conditions and genetic backgrounds. These technologies will collectively advance our understanding of sugar transport dynamics in plants and potentially identify novel regulatory mechanisms with implications for crop improvement strategies .